| Project/Area Number |
09672323
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
応用薬理学・医療系薬学
|
|---|
| Research Institution | KYOTO UNIVERSITY |
|---|
Principal Investigator |
HASHIMOTO Yukiya Graduate School of Medicine, Kyoto University Associate Professor, 医学研究科, 助教授 (90228429)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OKUDA Masahiro Graduate School of Medicine, Kyoto University Instructor, 医学研究科, 助手 (70252426)
YANO Ikuko Graduate School of Medicine, Kyoto University Instructor, 医学研究科, 助手 (50273446)
|
|---|
| Project Period (FY) |
1997 – 1998
|
| Project Status |
Completed (Fiscal Year 1998)
|
| Budget Amount *help |
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1997: ¥1,900,000 (Direct Cost: ¥1,900,000)
|
|---|
| Keywords | phenytoin / population pharmacokinetics / CYP2C9 / CYP2C19 / genetic polymorphism / non-linear pharmacokinetics / p450 / drug metabolism |
|---|
| Research Abstract |
We have estimated the population pharmacokinetic parameters of phenytoin in Japanese patients with epilepsy (Biol. Pharm. Bull., 19, 444, 1996), and examined the effect of cytochrome P450 (CYP) 2C9/19 polymorphisms on the pharmacokinetics of phenytoin (Clin. Pharmacol. Ther., 62, 287, 1997). In this study, we evaluated the phenytoin dosage regimen based on the simple polymerase chain reaction-based genetic test of CYP2C isozymes. The population pharmacokinetic parameters without the information of CYP2C genotypes failed to predict the serum phenytoin concentration in patients with the mutation in CYP2C9 (Ile^<359>*Leu). In contrast, the genotyping of CYP2C9/19 in individual patients was useful in determining which patients are at risk for drug intoxication. In addition, the precision of the predicted serum phenytoin concentrations was improved by the baysian analysis based on the population pharmacokinetic parameters involving the polymorphism of CYP2C subfamily. The genetic test for the CYP2C isozymes will be useful in designing the dosage of phenytoin.
|
